The private equity owners of Swedish mattress maker Hilding Anders are repaying some of the company's debt with a fresh 350 million euro ($468.49 million) investment from KKR and extending the maturity of the company's loans, bankers told Reuters.
2 min read · 09 August 2013
BlackBerry Ltd is warming up to the possibility of going private, as the smartphone maker battles to revive its fortunes, sources told Reuters.
3 min read · 09 August 2013
Energy focused private equity firm Riverstone Holdings will list a new energy vehicle - Riverstone Energy - on the London Stock Exchange, the Financial Times reported on Thursday, citing people familiar with the matter.
1 min read · 08 August 2013
T. Rowe Price Associates, one of the most influential opponents of Michael Dell's offer to buy out Dell Inc for about $25 billion, reduced its ownership in the struggling PC maker to a 2.8 percent stake from the 4 percent it held as of March 31, sources told Reuters.
2 min read · 08 August 2013
Private equity and credit investment firm Apollo Global Management LLC on Thursday reported a tenfold increase in second-quarter profit as the value of its funds jumped, and it announced its highest dividend since it went public in 2011, Reuters reported.
2 min read · 08 August 2013
GlaxoSmithKline on Thursday announced a $50 million venture fund and said the fund's first investment was made in SetPoint Medical, which is working on implantable devices to treat inflammatory diseases, Reuters reported.
2 min read · 08 August 2013
Investors in TPG Capital's flagship buyout fund have agreed to give the U.S. private equity firm more time to spend its undeployed capital, Reuters reported.
2 min read · 08 August 2013
Hilton Worldwide Inc, which is backed by Blackstone, has selected banks to lead an initial public offering, sources told Reuters.
1 min read · 07 August 2013
About seven bidders are lining up for Telediffusion de France's (TDF) domestic business and lenders are preparing debt packages of more than 2 billion euros ($2.7 billion) for a deal worth about 4 billion euros, sources told Reuters.
2 min read · 07 August 2013
TPG Capital LP has been exploring a sale of Aptalis Pharma, a specialty drugmaker it has owned since 2008 and values at more than $3 billion, sources told Reuters.
2 min read · 07 August 2013
